share_log

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga ·  Apr 2 12:31

Gainers

  • Nexalin Technology (NASDAQ:NXL) stock increased by 47.9% to $2.81 during Tuesday's regular session. The market value of their outstanding shares is at $20.4 million.
  • MSP Recovery (NASDAQ:LIFW) shares moved upwards by 33.26% to $0.89. The market value of their outstanding shares is at $13.1 million.
  • Aditxt (NASDAQ:ADTX) shares increased by 19.09% to $3.79. The market value of their outstanding shares is at $6.3 million.
  • Q32 Bio (NASDAQ:QTTB) shares increased by 17.69% to $21.18. The company's market cap stands at $252.7 million.
  • Evaxion Biotech (NASDAQ:EVAX) stock rose 16.4% to $3.76. The market value of their outstanding shares is at $18.0 million. As per the news, the Q4 earnings report came out 4 days ago.
  • Concord Medical Services (NYSE:CCM) shares rose 15.38% to $0.6. The market value of their outstanding shares is at $26.0 million.

Losers

  • Acorda Therapeutics (NASDAQ:ACOR) stock decreased by 75.8% to $3.26 during Tuesday's regular session. The company's market cap stands at $4.0 million. The company's, Q4 earnings came out yesterday.
  • Gritstone Bio (NASDAQ:GRTS) stock declined by 48.94% to $1.2. The company's market cap stands at $117.6 million.
  • Orgenesis (NASDAQ:ORGS) stock fell 40.61% to $0.34. The company's market cap stands at $11.7 million.
  • Verve Therapeutics (NASDAQ:VERV) shares decreased by 36.28% to $8.15. The company's market cap stands at $681.4 million.
  • Yield10 Bioscience (NASDAQ:YTEN) shares decreased by 25.53% to $0.29. The company's market cap stands at $3.4 million. The company's, Q4 earnings came out yesterday.
  • GRI Bio (NASDAQ:GRI) stock decreased by 24.66% to $0.56.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment